| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.CYTOGFR.2004.06.004 |
| P698 | PubMed publication ID | 15561602 |
| P50 | author | Dominique Heymann | Q43131742 |
| P2093 | author name string | Yohann Wittrant | |
| Yannick Fortun | |||
| Francoise Redini | |||
| Steeve Kwan Tat | |||
| Sandrine Theoleyre | |||
| P433 | issue | 6 | |
| P921 | main subject | pathophysiology | Q1135939 |
| P304 | page(s) | 457-475 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Cytokine and Growth Factor Reviews | Q15763303 |
| P1476 | title | The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling | |
| P478 | volume | 15 |
| Q38965673 | A cellular automata model of bone formation |
| Q54431091 | A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus. |
| Q34171853 | A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures |
| Q34664057 | Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone |
| Q51684688 | Acute effects of dietary fatty acids on osteclastogenesis via RANKL/RANK/OPG system. |
| Q31063890 | Adjunctive antimicrobial photodynamic treatment of experimentally induced periodontitis in rats with ovariectomy |
| Q36063108 | Adjunctive effect of antimicrobial photodynamic therapy in induced periodontal disease. Animal study with histomorphometrical, immunohistochemical, and cytokine evaluation |
| Q34156735 | Alpha-Calcitonin Gene-Related Peptide Can Reverse The Catabolic Influence Of UHMWPE Particles On RANKL Expression In Primary Human Osteoblasts |
| Q37258283 | Alterations in the Synthesis of IL-1β, TNF-α, IL-6, and Their Downstream Targets RANKL and OPG by Mouse Calvarial Osteoblasts In vitro: Inhibition of Bone Resorption by Cyclic Mechanical Strain |
| Q26863493 | Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences |
| Q81888549 | Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Société Française de Rhumatologie, SFR) |
| Q35834684 | Antimicrobial photodynamic therapy minimizes the deleterious effect of nicotine in female rats with induced periodontitis |
| Q40284981 | Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer |
| Q33744420 | Areca nut extract protects against ovariectomy-induced osteoporosis in mice |
| Q47166692 | Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts |
| Q51154398 | Association of the (TTTA)n repeat polymorphism of CYP19 gene with bone mineral density in Greek peri- and postmenopausal women. |
| Q39177486 | Associations between polymorphisms of HLA-B gene and postmenopausal osteoporosis in Chinese Han population |
| Q37133071 | Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner |
| Q49979732 | B cell subset distribution is altered in patients with severe periodontitis. |
| Q89536683 | Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway |
| Q47194100 | Beyond Antibodies: B Cells and the OPG/RANK-RANKL Pathway in Health, Non-HIV Disease and HIV-Induced Bone Loss |
| Q24701763 | Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection |
| Q47438464 | Bioactive treatments in bone grafts for implant-based rehabilitation: Systematic review and meta-analysis |
| Q38673908 | Bioprinting and Organ-on-Chip Applications Towards Personalized Medicine for Bone Diseases. |
| Q34802870 | Bone Healing in Ovariectomized-rabbit Calvarial Defect with Tricalcium Phosphate Coated with Recombinant Human Bone Morphogenetic Protein-2 Genetically Engineered in Escherichia coli |
| Q26771376 | Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma |
| Q51565203 | Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study. |
| Q38494091 | Bone turnover markers for early detection of fracture healing disturbances: A review of the scientific literature |
| Q28611365 | Boon and Bane of Inflammation in Bone Tissue Regeneration and Its Link with Angiogenesis |
| Q97527734 | CSF-1 in Osteocytes Inhibits Nox4-mediated Oxidative Stress and Promotes Normal Bone Homeostasis |
| Q37668709 | Cell interactions in bone tissue engineering. |
| Q39137409 | Chrysoeriol isolated from Eurya cilliata leaves protects MC3T3‐E1 cells against hydrogen peroxide‐induced inhibition of osteoblastic differentiation |
| Q37133815 | Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension |
| Q37418258 | Colony-stimulating factor-1 (CSF-1) directly inhibits receptor activator of nuclear factor-{kappa}B ligand (RANKL) expression by osteoblasts |
| Q35617758 | Constitutive expression of cathepsin K in the human intervertebral disc: new insight into disc extracellular matrix remodeling via cathepsin K and receptor activator of nuclear factor-κB ligand |
| Q37571564 | Cord blood--an alternative source for bone regeneration |
| Q38161735 | Current therapeutic strategies and novel approaches in osteosarcoma |
| Q28067502 | Cytokine Profile in Chronic Periodontitis Patients with and without Obesity: A Systematic Review and Meta-Analysis |
| Q38010350 | Denosumab--a powerful RANKL inhibitor to stop lytic metastases and other bone loss actions by osteoclasts |
| Q42805731 | Deoxyactein stimulates osteoblast function and inhibits bone-resorbing mediators in MC3T3-E1 cells |
| Q92343929 | Development of calcific aortic valve disease: Do we know enough for new clinical trials? |
| Q39327736 | Differential Effects of IL-17A and TNF-α on Osteoblastic Differentiation of Isolated Synoviocytes and on Bone Explants from Arthritis Patients. |
| Q36491383 | Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases |
| Q30412235 | Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas |
| Q37594768 | Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors |
| Q35677638 | Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis |
| Q41874349 | Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling. |
| Q38264673 | Drug design strategies for the treatment of prostate cancer |
| Q38955517 | Drugs in early clinical development for the treatment of osteosarcoma |
| Q38129954 | Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma? |
| Q81356317 | Early effects of tocilizumab on bone and bone marrow lesions in a collagen-induced arthritis monkey model |
| Q36390099 | Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro |
| Q37083062 | Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis |
| Q34657931 | Effect of orthodontic forces on cytokine and receptor levels in gingival crevicular fluid: a systematic review |
| Q64267362 | Effectiveness of electric toothbrush as vibration method on orthodontic tooth movement: a split-mouth study |
| Q64891933 | Effects of RANKL, osteoprotegerin, calcium and phosphorus on survival and activation of Muscovy duck osteoclasts in vitro. |
| Q34332098 | Effects of alpha-calcitonin gene-related peptide on osteoprotegerin and receptor activator of nuclear factor-κB ligand expression in MG-63 osteoblast-like cells exposed to polyethylene particles. |
| Q34547523 | Effects of conjugated linoleic acid and exercise on bone mass in young male Balb/C mice |
| Q35808641 | Effects of erythropoietin on the bone microenvironment |
| Q64230351 | Effects of mechanical forces on osteogenesis and osteoclastogenesis in human periodontal ligament fibroblasts: A systematic review of studies |
| Q33580516 | Effects of neuropeptides and mechanical loading on bone cell resorption in vitro |
| Q38664528 | Effects of pulsed electromagnetic fields on postmenopausal osteoporosis |
| Q33716948 | Effects of total flavonoids from Drynariae Rhizoma prevent bone loss in vivo and in vitro |
| Q38207147 | Emerging therapeutic targets for osteoporosis treatment |
| Q54276180 | Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone. |
| Q53538395 | Estimation of bone loss biomarkers as a diagnostic tool for peri-implantitis. |
| Q41984586 | Evaluation of melatonin levels in saliva in gingivitis and periodontitis cases: A pilot study |
| Q37163213 | Evidence for a calcification process in the trabecular meshwork |
| Q60659190 | Expression of bone resorption genes in osteoarthritis and in osteoporosis |
| Q53622328 | Expression of neuropeptides and bone remodeling-related factors during periodontal tissue regeneration in denervated rats. |
| Q42948793 | Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival |
| Q90600722 | Femoral condylar necrosis: treatment with hyperbaric oxygen therapy |
| Q51135670 | Formulation and in vitro and in vivo evaluation of a new osteoprotegerin-chitosan gel for bone tissue regeneration. |
| Q36700779 | Functions of RANKL/RANK/OPG in bone modeling and remodeling |
| Q51558602 | Genetic variation in the TNFRSF11A gene encoding RANK is associated with susceptibility to Paget's disease of bone. |
| Q93140455 | Geniposide attenuates cadmium‑induced oxidative stress injury via Nrf2 signaling in osteoblasts |
| Q35238712 | Ghrelin Increases Beta-Catenin Level through Protein Kinase A Activation and Regulates OPG Expression in Rat Primary Osteoblasts |
| Q37200573 | Granulocyte colony-stimulating factor induces osteoblast apoptosis and inhibits osteoblast differentiation |
| Q30354085 | Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. |
| Q50618057 | High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue. |
| Q48149932 | Histological analysis and gene expression profile following augmentation of the anterior maxilla using rhBMP-2/ACS versus autogenous bone graft. |
| Q47310464 | Hyperbaric oxygen therapy modulates serum OPG/RANKL in femoral head necrosis patients. |
| Q91992936 | Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients |
| Q48184294 | IL-3 Differentially Regulates Membrane and Soluble RANKL in Osteoblasts through Metalloproteases and the JAK2/STAT5 Pathway and Improves the RANKL/OPG Ratio in Adult Mice. |
| Q24657159 | Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation |
| Q36387944 | Identification of key genes and pathways for peri-implantitis through the analysis of gene expression data |
| Q42834177 | Immunohistochemical analysis of low-grade and high-grade prostate carcinoma: relative changes of parathyroid hormone-related protein and its parathyroid hormone 1 receptor, osteoprotegerin and receptor activator of nuclear factor-kB ligand |
| Q41847832 | Increased serum OPG in atrophic nonunion shaft fractures |
| Q46130063 | Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms |
| Q46291802 | Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling |
| Q54338829 | Induction of prostaglandin E(2) and interleukin-6 in gingival fibroblasts by oral biofilms. |
| Q34115689 | Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women |
| Q34503355 | Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human |
| Q92351335 | Interference of miR-212 and miR-384 promotes osteogenic differentiation via targeting RUNX2 in osteoporosis |
| Q44022501 | KLF5 promotes cervical cancer proliferation, migration and invasion in a manner partly dependent on TNFRSF11a expression |
| Q28287394 | Key roles of the OPG-RANK-RANKL system in bone oncology |
| Q36981095 | Long-chain polyunsaturated fatty acids and the regulation of bone metabolism |
| Q42799147 | Mechanical loading differentially regulates membrane-bound and soluble RANKL availability in MC3T3-E1 cells |
| Q36366450 | Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. |
| Q37186468 | Mechanobiology of tooth movement |
| Q36076041 | Melatonin and oral cavity |
| Q36029570 | Meox2Cre-mediated disruption of CSF-1 leads to osteopetrosis and osteocyte defects |
| Q64076402 | Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice |
| Q34555532 | Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levels |
| Q36086080 | MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway |
| Q92494094 | Minocycline-loaded PLGA electrospun membrane prevents alveolar bone loss in experimental peridontitis |
| Q38068600 | Monoclonal antibodies for the treatment of osteoporosis |
| Q39142554 | NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases |
| Q52018491 | NFATc1 expression in the developing heart valves is responsive to the RANKL pathway and is required for endocardial expression of cathepsin K. |
| Q37935523 | New targets for intervention in the treatment of postmenopausal osteoporosis |
| Q40346323 | No association between selected candidate gene polymorphisms and severe chronic periodontitis |
| Q51760981 | Novel RANK antagonists for the treatment of bone-resorptive disease: theoretical predictions and experimental validation. |
| Q44001600 | Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. |
| Q39190775 | Osteoblast-osteoclast interactions |
| Q50130540 | Osteoblastic heparan sulfate regulates osteoprotegerin function and bone mass. |
| Q28077461 | Osteoblasts Are the Centerpiece of the Metastatic Bone Microenvironment |
| Q36973979 | Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading |
| Q36693328 | Osteoimmunology |
| Q35173349 | Osteoporosis in chronic obstructive pulmonary disease |
| Q38409333 | Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease |
| Q53619763 | Osteoprotegerin Levels Decrease in Abstinent Alcohol-Dependent Patients. |
| Q36273402 | Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort |
| Q39474045 | Osteoprotegerin deficiency leads to deformation of the articular cartilage in femoral head |
| Q37109337 | Osteoprotegerin disrupts peripheral adhesive structures of osteoclasts by modulating Pyk2 and Src activities. |
| Q41184194 | Osteoprotegerin exposure at different stages of osteoclastogenesis differentially affects osteoclast formation and function. |
| Q34950497 | Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis. |
| Q50436161 | Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity |
| Q35640787 | Osteoprotegerin in Cardiometabolic Disorders |
| Q36491545 | Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL |
| Q26748804 | Osteoprotegerin rich tumor microenvironment: implications in breast cancer |
| Q38741874 | Osteoprotegerin: A novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma. |
| Q50446121 | Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing loss. |
| Q41655118 | Oxidized Titanium Implants Enhance Osseointegration via Mechanisms Involving RANK/RANKL/OPG Regulation |
| Q38308220 | PTX3 stimulates osteoclastogenesis by increasing osteoblast RANKL production |
| Q48073269 | Palliative Oncology: Denosumab |
| Q55082811 | Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts. |
| Q36966222 | Pediatric bone density and fracture |
| Q46175204 | Periodontal ligament fibroblasts sustain destructive immune modulators of chronic periodontitis. |
| Q37862366 | Perspectives on the use of melatonin to reduce cytotoxic and genotoxic effects of methacrylate-based dental materials |
| Q34828137 | Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing |
| Q36824764 | Possible involvement of AMP-activated protein kinase in PGE1-induced synthesis of osteoprotegerin in osteoblasts |
| Q26750631 | Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma |
| Q47738511 | Prognostic Value of Osteoprotegerin and sRANKL in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-small Cell Lung Cancer |
| Q36203010 | Proteoglycans and osteolysis |
| Q36088188 | RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas |
| Q64939796 | RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review. |
| Q26747442 | RANK-RANKL signalling in cancer |
| Q47215322 | RANK/RANKL/OPG Expression in Rapid Maxillary Expansion. |
| Q90152388 | RANKL/RANK/OPG Pathway: A Mechanism Involved in Exercise-Induced Bone Remodeling |
| Q88622314 | Radiological, Histological and Chemical Analysis of Breast Microcalcifications: Diagnostic Value and Biological Significance |
| Q36731426 | Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies. |
| Q36860987 | Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. |
| Q55008249 | Role of Serum Osteoprotegerin as a Diagnostic Indicator of Primary Osteoporosis in Perimenopausal and Postmenopausal Women: An Indian Perspective. |
| Q57116604 | Role of TCF/LEF Transcription Factors in Bone Development and Osteogenesis |
| Q90250824 | Root Resorption Classifications: A Narrative Review and a Clinical Aid Proposal for Routine Assessment |
| Q36157326 | Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone |
| Q34993353 | Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages. |
| Q33289750 | Rutile and titanium particles differentially affect the production of osteoblastic local factors. |
| Q59049436 | Salivary Melatonin and the Severity of Attachment Loss: A Case-Control Study |
| Q51426858 | Serum bone turnover markers may be involved in the metastatic potential of lung cancer patients. |
| Q33307072 | Single nucleotide polymorphisms in bone turnover-related genes in Koreans: ethnic differences in linkage disequilibrium and haplotype |
| Q48177889 | Sodium butyrate has anti-proliferative, pro-differentiating, and immunomodulatory effects in osteosarcoma cells and counteracts the TNFα-induced low-grade inflammation. |
| Q44625527 | Static and dynamic cultivation of bone marrow stromal cells on biphasic calcium phosphate scaffolds derived from an indirect rapid prototyping technique |
| Q90225894 | Strontium inhibits osteoclastogenesis by enhancing LRP6 and β-catenin-mediated OPG targeted by miR-181d-5p |
| Q89563079 | Strontium ranelate inhibits wear particle-induced aseptic loosening in mice |
| Q27665673 | Structure-based development of a receptor activator of nuclear factor- B ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis |
| Q36591727 | TGF-beta1 on osteoimmunology and the bone component cells |
| Q37996112 | TRAF6 activation in multiple myeloma: a potential therapeutic target |
| Q37972139 | TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment. |
| Q37293344 | Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis. |
| Q28731449 | Targeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasis |
| Q51693699 | The Association Between Periodontal Inflammation and Labor Triggers (Elevated Cytokine Levels) in Preterm Birth: A Cross-Sectional Study. |
| Q39061470 | The Effect of Orthognathic Surgery on Osteoprotegerin as Immunological Caliper of Bone Healing |
| Q47167957 | The Effect of RANKL/OPG Balance on Reducing Implant Complications |
| Q36537771 | The Function of Naringin in Inducing Secretion of Osteoprotegerin and Inhibiting Formation of Osteoclasts |
| Q91687260 | The Influence of TLR4, CD14, OPG, and RANKL Polymorphisms in Periodontitis: A Case-Control Study |
| Q57790452 | The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung Metastases |
| Q26773017 | The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis |
| Q64062131 | The Molecular Mechanism of Vitamin E as a Bone-Protecting Agent: A Review on Current Evidence |
| Q84990028 | The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis |
| Q56546058 | The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat |
| Q50903399 | The effect of chronic long-term intermittent hypobaric hypoxia on bone mineral density in rats: role of nitric oxide. |
| Q41143290 | The effect of marrow stromal cells on TRAF6 expression levels in myeloma cells |
| Q60723669 | The effect of polyunsaturated fatty acids on bone health |
| Q36376105 | The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis |
| Q50105018 | The material and biological characteristics of osteoinductive calcium phosphate ceramics |
| Q37615017 | The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer |
| Q35838186 | The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues |
| Q37268896 | The role of T cells in osteoporosis, an update. |
| Q100512479 | The third case of TNFRSF11A-associated dysosteosclerosis with a mutation producing elongating proteins |
| Q53167439 | Titanium surfaces with nanotopography modulate cytokine production in cultured human gingival fibroblasts. |
| Q34118018 | Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium |
| Q35087758 | Treatment with N- and C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in IGF-I deficient mice |
| Q37641468 | Tumor-stroma co-evolution in prostate cancer progression and metastasis |
| Q24289320 | Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies |
| Q38139382 | Understanding the advances in biology of orthodontic tooth movement for improved ortho-perio interdisciplinary approach |
| Q38109107 | Using functional nanomaterials to target and regulate the tumor microenvironment: diagnostic and therapeutic applications |
| Q41854584 | VEGF and RANKL regulation of NFATc1 in heart valve development. |
| Q80805288 | Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis |
| Q38135885 | Vitamin D and bone health outcomes in older age. |
| Q36813284 | Vitamin D: the secosteroid hormone and human reproduction |
| Q88126401 | WITHDRAWN: Associations between polymorphisms of HLA-B gene and postmenopausal osteoporosis in Chinese Han population |
| Q29614274 | Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression |
| Q36467025 | Wnt-signaling-mediated antiosteoporotic activity of porcine placenta hydrolysates in ovariectomized rats |
| Q24316366 | α-Actinin-3 deficiency is associated with reduced bone mass in human and mouse |
Search more.